Cheapest One Way flight of a Month
Cheapest One Way flight of a Day
Cheapest Round Trip flight of a Month
Cheapest Round Trip flight of a Day
The national system of medicine like any complex configuration major system be subject to major changes if they reached their conditions to the brink of chaos , or to the status of «checkmate». Changes that occur in the midst of chaos , or the circumstances of the «checkmate» are not necessarily positive changes, which may be negative direction major carrier and systematic risk. Of the most important negative trends and risks to the national system for the drug is currently being sought by the establishment of the so-called Egyptian Drug Authority, as well as what had begun arise claims need to edit the price of drugs. 1 DRAFT Egyptian Drug Administration: Currently, it presented to parliament a draft resolution established by a law of the Egyptian Drug Administration. Three reasons for the need to avoid this project: • Lack of health promotion for the current absence of such a body. • Grandma disappearance of the functions and components of the project submitted compared to what exists. • move away from the draft submitted any innovations in a systematic, political strategy and technique, impose conditions needed basic menu. As for the details, Valtroyj of this body is based on the claim that it is concerned with the control of the drug, and that Egypt has no entity controlled on medication, and that is not right, given that other countries, such as Jordan and Saudi Arabia, have a national body for the drug censor it, but the mystery of Jordan's progress in export is the presence of Jordan's body medicine, and that there is also a Saudi unparalleled, under the name of Saudi Arabia drug Administration. The fact that this promotion is not based on any fact, as in Egypt supervisory entity with BS giant is the National Drug Authority for Monitoring and Research (Nodkar). Nodkar it has formed called this in 1976 through the consolidation of two entities Doaiaan Rkabaan nationalists, namely the Ministry of Health Pharmaceutical control coefficient (which originated in 1955) and the Centre for Research and Control Foundation pharmaceutical drugs (which was founded in 1963). This means that the national drug control in Egypt has been generated by similar entities in contracts sister countries, and indeed was the first at the level of developing countries. This, knowing that there is next to a giant entity «Nodkar» other complementary entities, two brothers, two controls on serums and vaccines body, the central management of the pharmacy. If the names of two of Drug Control in Jordan and Saudi Arabia have been designed to be nearly the same name of the corresponding device pattern in the United States (FDA) Food and Drug Amonistration, where the name of Jordan is (JFDA) Jordanian Food and Drug Authority, and in Saudi Arabia the same token ( SFDA), there is nothing to require that we follow in Egypt the same pattern shift to the name «Egyptian body medicine» Egyptian drug Authority so as to have the acronym in English EDA, and until it becomes like JFDA and SFDA, as the two sisters, Jordan and Saudi Arabia, respectively. Indeed, the designation of this entity and change the way vary from state to state. For example, in Germany, the so-called «Federal Institute for Drugs and Medical Supplies», and in Pakistan «controls on medicines Authority», and in Malaysia «National Office for the Control of Pharmaceutical substances», In South Africa «Drug Control Council», and in Poland «Drug Institute». As for the password on Jordan's progress on Egypt's pharmaceutical exports, he never returns to the existence of a body of Jordanian medicine, which is considered normal existence. It is due to that the Jordanian pharmaceutical industry, in spite of their novelty compared to major Egyptian her sister, with the highest diet in the development, which is in so do not wait to be forced to develop as a reaction to an emergency crisis (such as the crisis in Ethiopia's rejection drugs Egypt last summer). In addition, companies of Jordan has ambitions and practices of high efficiency in marketing. So as well as a deep interest for some Jordanian companies in scientific research and development, which is offset by the indifference of the Egyptian companies. As for the draft submitted, according to an articles, it does not add anything new about the tasks and objectives, techniques and relationships, what they are doing National Supervisory Authority and the Pharmaceutical Research and Rafiqtaha (control of serums and vaccines and centralized management of Pharmacy) body. We have submitted materials for the project included the pro forma things would never be policy Owalastratejaat; where busy Bouapoukrattiyat dependency and the transfer of existing government pharmaceutical entities already proposed to the body of the university bachelor's chief qualification and quality, and direct subordination to the Prime Minister. Only material that adds a new read are those that say: «allocated to the body area of not less than fifty acres in one of the new cities in Greater Cairo (such as the Badr City or other) to establish the necessary facilities to achieve its goals».
